Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by LouisW

T.TH

RE:RE:RE:RE:RE:Example of PR for Proof Of Concept

I don't understand. Could you please elaborate more?

October 24, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Designing the basket trials

I am a scientist working in the bioindustry for almost a decade. I think the...

October 17, 2022

T.TH

Can anyone have full access to obtain 2022Q3 transcript?

Could you please paste here? Thank you very much.

October 13, 2022

T.TH

RE:RE:Expectations too high. Reset your animus.

I remember you said that you or your friends meet with them quarterly, right?...

October 13, 2022

T.TH

RE:RE:RE:This week

I do agree with you. But recent bearish market is scary...i am looking...

October 11, 2022

T.TH

RE:Share Price Appreciation Expectations?

Since immunomedics is THTXs model, we can refer to immunomedics history. How...

October 6, 2022

T.TH

RE:THTX's NASH protocol's advantages

Just curious.....Does other therapies include HIV patient? If HIV is not...

October 4, 2022

T.TH

Water information, reverified in mid September

https://www.accessdata.fda.gov/scripts/drugshortages/dsp...

October 3, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Montreal's Ventus Therapeutics

The potential of tesamorelin is not only in NASH but also in prevention from...

September 30, 2022

T.TH

RE:RE:What's Going on in US Premarket?

If so, the PR would be released prior to the meeting.

September 26, 2022

T.TH

RE:Cancer Moonshot Initiative

Not sure if this policy is limited to US based company.....

September 13, 2022

T.TH

RE:RE:RE:PUMP and DUMP ?

I am imaging what the SP might be if we announce TH1902 partnership, Ph2...

September 13, 2022

T.TH

RE:Long, very long

I think to conduct early trial like 1b without SORT1 expression data is...

August 23, 2022

T.TH

RE:RE:Compensation??

I think it is typical. When I participated the trial for testing COVID19...

August 22, 2022

T.TH

RE:RE:RE:September expectations

Paul mentioned on the Q2 finacial meeting that they will probably announced...

August 16, 2022

T.TH

RE:September expectations

I would expect mid October prior to the Financial meeting rather than...

August 15, 2022

T.TH

RE:NASH

I dont know what was going on on the post. Let me post again. To me, the...

August 12, 2022

T.TH

NASH

NASH NASH 2022 3 “”“” NASH PR

August 12, 2022

T.TH

9% in pre-market

Hopes something meamingful can be announced.

August 10, 2022

T.TH

RE:RE:RE:RE:Getting rich or getting a return

Sorry. The question is for SPCEO.....thanks.

August 9, 2022

Prev 1 2 3 4 5 6 7 8 9 10 Next

Featured Company

Theralase Technologies Inc.

Theralase Technologies Inc. V.TLT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research ... view more »